Propanc Biopharma, Inc. is a biopharmaceutical company developing pancreatic proenzyme-based therapies to prevent recurrence and metastasis of solid tumors by targeting cancer stem cells. Its lead product, PRP, is an intravenous combination of trypsinogen and chymotrypsinogen. The company has completed pre-clinical studies and plans a Phase Ib First-In-Human clinical trial in 2026, targeting pancreatic, ovarian, and colorectal cancers.
Q2 FY2026 — expected 2026-08-21
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-09-25 | 2026-06-30 | 0001493152-26-044373 | EDGAR | 83K words |
| 2025-09-29 | 2025-06-30 | 0001493152-25-016069 | EDGAR | 81K words |
| 2024-09-30 | 2024-06-30 | 0001493152-24-038815 | EDGAR | 72K words |
| 2023-09-28 | 2023-06-30 | 0001493152-23-034632 | EDGAR | 78K words |
| 2022-09-28 | 2022-06-30 | 0001493152-22-027033 | EDGAR | — |
| 2021-09-28 | 2021-06-30 | 0001493152-21-023973 | EDGAR | — |
| 2020-10-01 | 2020-06-30 | 0001493152-20-018726 | EDGAR | — |
| 2019-10-15 | 2019-06-30 | 0001493152-19-015529 | EDGAR | — |
| 2018-09-17 | 2018-06-30 | 0001493152-18-013392 | EDGAR | — |
| 2017-09-28 | 2017-06-30 | 0001493152-17-011027 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-17 | 2025-12-31 | 0001493152-26-007052 | EDGAR | 41K words |
| 2025-11-14 | 2025-09-30 | 0001493152-25-023213 | EDGAR | 36K words |
| 2025-05-15 | 2025-03-31 | 0001641172-25-010798 | EDGAR | 41K words |
| 2025-02-14 | 2024-12-31 | 0001493152-25-006697 | EDGAR | 35K words |
| 2024-11-14 | 2024-09-30 | 0001493152-24-045664 | EDGAR | 31K words |
| 2024-05-15 | 2024-03-31 | 0001493152-24-019940 | EDGAR | 42K words |
| 2024-02-20 | 2023-12-31 | 0001493152-24-007191 | EDGAR | 39K words |
| 2023-11-14 | 2023-09-30 | 0001493152-23-040980 | EDGAR | 35K words |
| 2023-05-15 | 2023-03-31 | 0001493152-23-017346 | EDGAR | 43K words |
| 2023-02-10 | 2022-12-31 | 0001493152-23-004150 | EDGAR | — |
| 2022-11-14 | 2022-09-30 | 0001493152-22-032116 | EDGAR | — |
| 2022-05-16 | 2022-03-31 | 0001493152-22-013577 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-07-14 | 0001493152-26-033173 | EDGAR | 3K words |
| 2026-02-26 | 0001493152-26-008196 | EDGAR | 7K words |
| 2026-01-07 | 0001493152-26-000834 | EDGAR | 1K words |
| 2025-11-10 | 0001493152-25-021567 | EDGAR | 26K words |
| 2025-10-14 | 0001493152-25-018054 | EDGAR | 29K words |
| 2025-08-19 | 0001641172-25-024872 | EDGAR | 1K words |
| 2025-08-13 | 0001641172-25-023580 | EDGAR | 1K words |
| 2025-07-30 | 0001641172-25-021560 | EDGAR | 7K words |
| 2025-07-22 | 0001641172-25-020574 | EDGAR | 3K words |
| 2025-06-27 | 0001641172-25-016719 | EDGAR | 7K words |
227 total filings indexed. 195 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001517681 |
| Ticker | PPCB |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.propanc.com |
| Listed | 2012-06-15 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/PPCB (~200 tokens, structured JSON with cryptographic provenance)